High impact
OfficeLink Updates - July 2025 notices and reminders (PDF)
Aetna·Effective Jun 18, 2025
Aetna has updated its National Precertification List (NPL) with multiple changes effective June-July 2025, requiring new prior authorization for several specialty drugs (denosumab, ustekinumab, tocilizumab variants) while removing precertification requirements for electric scooters, orthognathic surgery, TMJ procedures, and Medicare hyperbaric oxygen therapy. Additionally, certain oncology immune checkpoint inhibitors will have reduced 90-day initial approval periods when administered in outpatient hospital settings starting October 1, 2025.